Literature DB >> 9618942

The exogenous NADH dehydrogenase of heart mitochondria is the key enzyme responsible for selective cardiotoxicity of anthracyclines.

H Nohl1, L Gille, K Staniek.   

Abstract

The molecular mechanism of the anthracycline-dependent development of cardiotoxicity is still far from being clear. However, it is generally accepted, that mitochondria play a significant role in triggering this organ specific injury. The results presented in this study demonstrate that, in contrast to liver mitochondria, isolated heart mitochondria shuttle single electrons to adriamycin, giving rise to oxygen radical formation via autoxidation of adriamycin semiquinones. This one electron reduction of anthracyclines is catalyzed by the exogenous NADH dehydrogenase associated with complex I of heart mitochondria, an enzyme which is lacking in liver mitochondria. Upon addition of NADH heart mitochondria generate significant amounts of adriamycin semiquinones while liver mitochondria were ineffective. Adriamycin semiquinones undergo both autoxidation leading to superoxide radical release and complex reactions under formation of adriamycin aglycone. Due to the high lipophilicity adriamycin aglycones accumulate in the inner mitochondrial membrane where they interfere with electron carriers of the respiratory chain. Adriamycin aglycone semiquinones emerging from an interaction with complex I were found to trigger homolytic cleavage of H2O2 which results in the formation of hydroxyl radicals. As demonstrated in this study the activation of adriamycin by the exogenous NADH dehydrogenase of cardiac mitochondria initiates a cascade of reaction steps leading to the establishment of oxidative stress. Our experiments suggest the exogenous NADH dehydrogenase of heart mitochondria to play a key role in the cardiotoxicity of adriamycin. This organ-specific enzyme initiates a sequence of one electron transfer reactions ending up in the establishment of oxidative stress.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618942     DOI: 10.1515/znc-1998-3-419

Source DB:  PubMed          Journal:  Z Naturforsch C J Biosci        ISSN: 0341-0382


  9 in total

Review 1.  New insights into type II NAD(P)H:quinone oxidoreductases.

Authors:  Ana M P Melo; Tiago M Bandeiras; Miguel Teixeira
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

Review 2.  Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications.

Authors:  Lei Xi; Shu-Guang Zhu; Anindita Das; Qun Chen; David Durrant; Daniel C Hobbs; Edward J Lesnefsky; Rakesh C Kukreja
Journal:  Nitric Oxide       Date:  2012-04-05       Impact factor: 4.427

3.  Beta-adrenergic receptor mediated protection against doxorubicin-induced apoptosis in cardiomyocytes: the impact of high ambient glucose.

Authors:  Naohiro Yano; Daisuke Suzuki; Masayuki Endoh; Andy Tseng; Joan P Stabila; Bethany G McGonnigal; Ting C Zhao; James F Padbury; Yi-Tang Tseng
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

Review 4.  Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of action.

Authors:  Saad Shaaban; Amr Negm; Elsayed E Ibrahim; Ahmed A Elrazak
Journal:  Oncol Rev       Date:  2014-05-28

5.  Effects of Calorie Restriction and Voluntary Exercise on Doxorubicin-Induced Cardiotoxicity.

Authors:  Stephanie E Hall; Ashley J Smuder; Reid Hayward
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

6.  Impact of breast cancer and combination chemotherapy on oxidative stress, hepatic and cardiac markers.

Authors:  Kamal Adel Amin; Basant Mahmoud Mohamed; Mohamed Aly M El-Wakil; Sanaa Omar Ibrahem
Journal:  J Breast Cancer       Date:  2012-09-28       Impact factor: 3.588

7.  Central carbon metabolism in the progression of mammary carcinoma.

Authors:  Adam D Richardson; Chen Yang; Andrei Osterman; Jeffrey W Smith
Journal:  Breast Cancer Res Treat       Date:  2007-09-19       Impact factor: 4.872

8.  Scientific validation of cardioprotective attribute by standardized extract of Bombyx mori against doxorubicin-induced cardiotoxicity in murine model.

Authors:  Masood S Khan; Mhaveer Singh; Mohammad A Khan; D S Arya; Sayeed Ahmad
Journal:  EXCLI J       Date:  2014-09-05       Impact factor: 4.068

Review 9.  Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines.

Authors:  Derek W Edwardson; Rashmi Narendrula; Simon Chewchuk; Kyle Mispel-Beyer; Jonathan P J Mapletoft; Amadeo M Parissenti
Journal:  Curr Drug Metab       Date:  2015       Impact factor: 3.731

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.